Anticipated Shortage

ERYTHROCIN I.V.

AMDIPHARM LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ERYTHROCIN I.V. in Canada?

A shortage of ERYTHROCIN I.V. 1G is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 8, 2026), but it has not started yet.

Why is ERYTHROCIN I.V. not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will ERYTHROCIN I.V. be available again?

The manufacturer's estimated resolution date is April 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusAnticipated Shortage

Same-ingredient products on file1 product · 0 same form & route

Expected resolution~6 months remaining (estimate)

Affected strength1G

Report last updated2026-09-08

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ERYTHROMYCIN

PHARMA STULLN INC.

5MG · DIN 02141574

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00682276

Strength

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

ERYTHROMYCIN

See all ERYTHROMYCIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-08

Anticipated Shortage

Shortage of an active ingredient.

Other Products from AMDIPHARM LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ANDROCUR

50MG · DIN 00704431

EES 600 TABLETS 600MG

600MG · DIN 00583782

40MG · DIN 00000299

400MG · DIN 00453617

500MG · DIN 00893862

500MG · DIN 00682268